rs199938599

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The ENST00000260648.10(PREPL):​c.217A>G​(p.Lys73Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000247 in 1,601,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K73N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

PREPL
ENST00000260648.10 missense, splice_region

Scores

3
16
Splicing: ADA: 0.003594
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.89

Publications

3 publications found
Variant links:
Genes affected
PREPL (HGNC:30228): (prolyl endopeptidase like) The protein encoded by this gene belongs to the prolyl oligopeptidase subfamily of serine peptidases. Mutations in this gene have been associated with hypotonia-cystinuria syndrome, also known as the 2p21 deletion syndrome. Several alternatively spliced transcript variants encoding either the same or different isoforms have been described for this gene.[provided by RefSeq, Jan 2010]
PREPL Gene-Disease associations (from GenCC):
  • hypotonia-cystinuria syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • myasthenic syndrome, congenital, 22
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06994799).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PREPLNM_001171613.2 linkc.-49+1881A>G intron_variant Intron 1 of 13 ENST00000409411.6 NP_001165084.1 Q4J6C6-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PREPLENST00000409411.6 linkc.-49+1881A>G intron_variant Intron 1 of 13 1 NM_001171613.2 ENSP00000387095.2 Q4J6C6-4

Frequencies

GnomAD3 genomes
AF:
0.000269
AC:
41
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000183
AC:
46
AN:
251098
AF XY:
0.000192
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000244
AC:
354
AN:
1449652
Hom.:
0
Cov.:
30
AF XY:
0.000234
AC XY:
169
AN XY:
721834
show subpopulations
African (AFR)
AF:
0.0000604
AC:
2
AN:
33116
American (AMR)
AF:
0.000291
AC:
13
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26070
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39616
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85970
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5158
European-Non Finnish (NFE)
AF:
0.000292
AC:
322
AN:
1101668
Other (OTH)
AF:
0.000200
AC:
12
AN:
59962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000269
AC:
41
AN:
152186
Hom.:
0
Cov.:
32
AF XY:
0.000269
AC XY:
20
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41436
American (AMR)
AF:
0.00144
AC:
22
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000220
AC:
15
AN:
68030
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000252
Hom.:
0
Bravo
AF:
0.000238
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.000273
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Myasthenic syndrome, congenital, 22 Uncertain:1
Jan 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 73 of the PREPL protein (p.Lys73Glu). This variant is present in population databases (rs199938599, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with PREPL-related conditions. ClinVar contains an entry for this variant (Variation ID: 578461). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Jun 18, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.217A>G (p.K73E) alteration is located in exon 1 (coding exon 1) of the PREPL gene. This alteration results from a A to G substitution at nucleotide position 217, causing the lysine (K) at amino acid position 73 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.011
T;T;T;T;.;.;T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.094
FATHMM_MKL
Benign
0.52
D
LIST_S2
Benign
0.77
.;.;.;T;T;T;T
M_CAP
Benign
0.0034
T
MetaRNN
Benign
0.070
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N;N;N;N;N;N;.
PhyloP100
1.9
PrimateAI
Uncertain
0.48
T
PROVEAN
Benign
0.020
N;N;N;N;N;N;N
REVEL
Uncertain
0.31
Sift
Benign
0.035
D;D;D;D;D;D;D
Sift4G
Benign
0.14
T;T;T;T;T;T;D
Polyphen
0.0010
B;B;B;B;B;B;.
Vest4
0.58
MVP
0.29
MPC
0.0043
ClinPred
0.017
T
GERP RS
4.1
PromoterAI
-0.0092
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.11
gMVP
0.48
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0036
dbscSNV1_RF
Benign
0.058
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199938599; hg19: chr2-44586638; API